Switzerland Cannabis Markets Report 2023: Comprehensive Guide to the Size and Shape of this Emerging Market – Forecasts to 2027 – ResearchAndMarkets.com

By -
DUBLIN--(BUSINESS WIRE)--The "Cannabis in Switzerland" report has been added to ResearchAndMarkets.com's offering. The Cannabis in Switzerland market report offers a comprehensive guide to the size and shape of this emerging market opportunity at a national level. It provides the latest retail sales data (historic date range), allowing you to identify the key cannabinoid categories driving growth. Following the current liberalisation of medical cannabis, the trend towards liberalisation of adult-use cannabis is also expected over the forecast period. The consumption of products bought on the black market carries the risk of containing dangerous harmful substances or synthetic cannabinoids. For this reason, Swiss authorities will likely seek a compromise between prohibition and absolute legalisation of cannabis. It outlines the regulatory, cultural and commercial context and offers strategic analysis of key factors influencing the market - legislative developments both current and future, economic/lifestyle influences, illicit consumption, product innovation, distribution and pricing trends. Forecasts to 2027 illustrate how the market is set to expand and change. Product coverage: Adult-Use Cannabis, CBD, Medical Cannabis. Data coverage: Market sizes (historic and forecasts), company shares, brand shares and distribution data. Why buy this report? Get a detailed picture of the Cannabis market; Pinpoint growth sectors and identify factors driving change; Understand the competitive environment, the market's major players and leading brands; Use five-year forecasts to assess how the market is predicted to develop. Key Topics Covered: CANNABIS IN SWITZERLAND EXECUTIVE SUMMARY CANNABIS BACKGROUND COUNTRY INSIGHT CANNABIS LEGISLATION CANNABIS DISTRIBUTION CANNABIS TAXATION CANNABIS PRODUCTION ILLICIT CANNABIS MARKET MARKET INDICATORS Cannabis User Population by Legal vs Illicit 2019-2022 MARKET DATA Sales of Cannabis by Category: Value 2019-2022 Sales of Cannabis by Category: % Value Growth 2019-2022 Sales of Cannabis by Legal vs Illicit 2019-2022 Distribution of Cannabis by Format: % Value 2019-2022 Distribution of Cannabis by Format and Category: % Value 2022 Forecast Sales of Cannabis by Category: Value 2022-2027 Forecast Sales of Cannabis by Category: % Value Growth 2022-2027 Forecast Sales of Cannabis by Legal vs Illicit 2022-2027 MEDICAL CANNABIS Market Sizes Cannabinoids Brands Distribution CATEGORY DATA Sales of Medical Cannabis by Category: Volume 2019-2022 Sales of Medical Cannabis by Category: Value 2019-2022 Sales of Medical Cannabis by Category: % Volume Growth 2019-2022 Sales of Medical Cannabis by Category: % Value Growth 2019-2022 Sales of Medical Cannabis by CBD vs THC content: % Value 2019-2022 Distribution of Medical Cannabis by Format: % Value 2019-2022 Forecast Sales of Medical Cannabis by Category: Volume 2022-2027 Forecast Sales of Medical Cannabis by Category: Value 2022-2027 Forecast Sales of Medical Cannabis by Category: % Volume
http://dlvr.it/ShR6C2

Comments

Post a Comment

Popular posts from this blog

Hempy 2014!

By -
Image
I started 2013 with a basement full of weed and an empty bank account. I don’t know of any Seattle growers that actually got rich from growing pot this year. I think a lot of us unemployed corporate types who were laid off saw the opportunity to work for ourselves until the state could figure out what to do with the future of medical and voter approved recreational pot. A year later, the future of  medical marijuana in Washington State is still tenuous.  I have personally witnessed healing in people who use cannabis as medicine and I think it’s a crime that providers have been thrown in jail for helping others. Cannabis IS medicine and we have a God-given right to have access to it. Dispensary “donations” were my main source of income in 2013. I make half of what I used to back in my VC-funded days, but I don’t care. Money is not it. Helping people, and loving what you do on a daily basis where it’s at, man. The meaning of life is to be of service to others. Working
Read more

Coming Out of the Pot Closet

By -
Image
I have to vacuum before my mother arrives from Arizona. I’m 40-something years old and I still want her housekeeping approval. While we’re close, and speak on the phone every week, we haven’t seen each other 1:1 for a while. I’m freaking out because I think she’ll have an aneurysm when I tell her how I’ve been paying my bills the past three years. Garden of Eve The time has arrived for me to come out of the Pot Closet to my mother. How did I get here? I was laid off from my event-planning job while dating a “normal-looking” guy, who owned his own landscaping business. “Larry” also happen to own a basement full of marijuana plants for extra spending money (on prostitutes, as it turns out, but that’s a different blog post). He taught me everything I know about being a Pharmer -- from cloning and transplanting, to providing my babies with the proper nutrients and watering techniques.  I learned a lot – about the miraculous cannabis plant, and about the lying, cheating asshol
Read more

PureTech Provides End of Year Report on Key Progress

By -
Image
BOSTON--(BUSINESS WIRE)--PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) (“PureTech” or the “Company”), a clinical-stage biotherapeutics company dedicated to changing the treatment paradigm for devastating diseases, today reported on the key progress made across its Wholly Owned Programs1 and Founded Entities2 in 2022. Daphne Zohar, Founder and Chief Executive Officer of PureTech, commented: “2022 has been a particularly successful and productive year in both crystallizing value and shaping the future of PureTech. Our primary focus is to progress our Wholly Owned Pipeline to commercialization and deliver new classes of medicines for patients with serious, debilitating conditions. We are advancing toward this goal by deepening our commitment to programs with compelling clinical data that are moving into late-stage studies and that we believe have the potential for broad impact. “Over the next 12 months, we anticipate multiple important catalysts that will further guide how we prioritize o
Read more